跳至主要内容
临床试验/IRCT2015042114333N32
IRCT2015042114333N32已完成2 期

Comparating the effect of combination and single therapy of exjade and desferal on ferritin level in patients with major thalassemia

Kermanshahu University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 18 years(—)
性别
All

入选标准

  • Inclusion: being younger than 18; having thalasemia major based on observing clinical symptoms and hemoglobin electrophoresis history; being treated by deferoxamine hypodermic injection and ferritin level 1000 to 3000. Exclusion:inability to digest exjade; hepatitis virologic; LFT; active hepatitis; noncompliance with previous treatment regimens; ALT and AST normal up to 3 times

排除标准

  • 未提供

研究者

发起方
Kermanshahu University of Medical Sciences

相似试验

The effect of therapy of exjade and desferal on... | 临床试验